Safety Study of a Novel Wearable Phototherapy System for the Management of Acute Burn Wounds

Inclusion Criteria: * Patients receiving care at Shriners Hospitals for Children-Boston for a skin tissue injury. * Patients who have at least one wound with exposed area sufficient, in the Investigator's opinion, to receive LIMB therapy. * Willing and able to adhere to daily LIMB therapy protocol. Exclusion Criteria: * Patients deemed not medically stable by the treating Investigator. * Patients with clinical signs and symptoms of systemic infection at baseline. * Patients with burn wounds limited to their head and genitalia. * Patients who, in the opinion of the Investigator, will not require daily dressing changes. * Patients receiving photosensitizing agents that result in cutaneous phototoxicity prior to enrollment. Patients who have received one or more of the following photosensitizers cannot be enrolled into the study: photofrin, amiodarone, chloropromazine, fluoroquinolone antibiotics, thiazide diuretics, quinine, demethylchlortetracycline, psoralens, nalidixic acid, tetracycline, naproxen. * Patients currently enrolled or participating in another investigational device, drug or biological trial within 30 days of the Screening Visit. * Patients currently receiving any bandages or devices containing silver compounds. * Patients on a ventilator, who have fluid resuscitation or are in any terminal condition.